LEO15520, a novel selective p38 map kinase inhibitor with strong anti-inflammatory efficacy in vivo

被引：0
|
作者：
Jensen, Lene
Aaes, H.
Boehncke, W-H
Pfeffer, J.
Skak-Nielsen, T.
Teige, I.
Abell, K.
Kvist, P. H.
Ottosen, E.
Petersen, T. K.
Svensson, Lars
机构：
[1] LEO Pharma, Ballerup, Denmark
[2] Univ Frankfurt, Dept Dermatol, D-6000 Frankfurt, Germany
来源：
INFLAMMATION RESEARCH | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S403 / S403
页数：1
相关论文
共 50 条
  • [11] Anti-inflammatory effects of a p38 MAP kinase inhibitor, doramapimod, against bacterial cell wall toxins in equine whole blood
    Bauquier, Jennifer R.
    Tennent-Brown, Brett S.
    Tudor, Elizabeth
    Bailey, Simon R.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2020, 220
  • [12] Synthesis of a naphthyridone p38 MAP kinase inhibitor
    Chung, John Y. L.
    Cvetovich, Raymond J.
    McLaughlin, Mark
    Amato, Joseph
    Tsay, Fuh-Rong
    Jensen, Mark
    Weissman, Steve
    Zewge, Daniel
    JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (22): : 8602 - 8609
  • [13] Practical Synthesis of a p38 MAP Kinase Inhibitor
    Achmatowicz, Michal
    Thiel, Oliver R.
    Wheeler, Philip
    Bernard, Charles
    Huang, Jinkun
    Larsen, Robert D.
    Faul, Margaret M.
    JOURNAL OF ORGANIC CHEMISTRY, 2009, 74 (02): : 795 - 809
  • [14] Mechanism of p38 MAP kinase activation in vivo
    Brancho, D
    Tanaka, N
    Jaeschke, A
    Ventura, JJ
    Kelkar, N
    Tanaka, Y
    Kyuuma, M
    Takeshita, T
    Flavell, RA
    Davis, RJ
    GENES & DEVELOPMENT, 2003, 17 (16) : 1969 - 1978
  • [15] Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase
    Cumming, JG
    McKenzie, CL
    Bowden, SG
    Campbell, D
    Masters, DJ
    Breed, J
    Jewsbury, PJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5389 - 5394
  • [16] Novel p38 MAP kinase inhibitor and anti-p38 RNA interference as potential therapeutic approaches in myelodysplastic syndromes
    Mohindru, M
    Pahanish, P
    Katsoulidis, E
    Collins, R
    Rogers, T
    Navas, T
    Higgins, L
    Platanias, L
    Verma, A
    BLOOD, 2004, 104 (11) : 137A - 137A
  • [17] A novel strategy demonstrates conclusively the involvement of p38 alpha MAP kinase in the production of the anti-inflammatory cytokine IL-10
    Guo, X
    Salmon, RA
    Schrader, JW
    FASEB JOURNAL, 2000, 14 (06): : A1083 - A1083
  • [18] Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia
    Branger, J
    van den Blink, B
    Weijer, S
    Madwed, J
    Bos, CL
    Gupta, A
    Yong, CL
    Polmar, SH
    Olszyna, DP
    Hack, CE
    van Deventer, SJH
    Peppelenbosch, MP
    van der Poll, T
    JOURNAL OF IMMUNOLOGY, 2002, 168 (08): : 4070 - 4077
  • [19] Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats
    Koch, Diana A.
    Silva, Rodrigo B. M.
    de Souza, Alessandra H.
    Leite, Carlos E.
    Nicoletti, Natalia F.
    Campos, Maria M.
    Laufer, Stefan
    Morrone, Fernanda B.
    RHEUMATOLOGY, 2014, 53 (03) : 425 - 432
  • [20] Suppression of ex vivo cytokine production by SB-242235, a selective inhibitor of p38 map kinase.
    Fullerton, T
    Sharma, A
    Prabhakar, U
    Tucci, M
    Boike, S
    Davis, H
    Jorkasky, D
    Williams, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 114 - 114
12345